Federal National Mortgage
Association (PINK: FNMA) $0.52 Stock has popped 13.38%
as the secondary mortgage purchaser is seeing increased activity from
speculation that the government regulators might privatize its entity. 11.8
million shares have been traded so far compare to its average volume of 7.4
million for the past three months.
Federal National Mortgage Association (Fannie Mae), a government-sponsored enterprise, provides liquidity and stability support in the secondary mortgage market in the United States. It securitizes mortgage loans originated by lenders in the primary mortgage market into mortgage-backed securities, which are bought and sold in the secondary mortgage market.
Federal Home Loan Mortgage Corp (PINK:
FREJN) $1.35 Price per share surged 22.73%
this morning with an even 4 million volume of shares traded at midday. As you
know Freddie Mac along with Fannie Mae have been under the scope as there are
current talks that both secondary mortgage purchasers are planning to be
structured as private entities. Even though the future is uncertain at this
point for both companies, it would be wise to put these stocks on your watch
list.
Freddie Mac provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities. It operates in three segments: Investments, Single-Family Guarantee, and Multifamily. The Investments segment invests principally in mortgage-related securities and single-family mortgage loans; purchases mortgage loans and mortgage-related securities; and issues short-and long-term debt in the capital markets.
Entest BioMedical Inc. (PINK:
ENTB) $3.87 Stock increased by 7.5% with a
relatively low volume of 30K. It is something to keep an eye on especially if
the volume starts steadily increasing. Company has been diligently persistent
in attempting to grow its revenues, but the lack of liquidity at this point
keeps investors at bay. Recently CEO announced that they plan to acquire
additional clinics and move things forward on ImenVax 10 Dog Safe Study.
Entest BioMedical Inc. is a developer of veterinary medicines
that harness the animal's own reparative / immunological mechanisms. The
company's products include an immuno-therapeutic cancer vaccine for canines
(ImenVax™). The company's immuno-therapeutic cancer vaccine utilizes an
encapsulation device as the vaccine delivery system and requires a simple
implant procedure.
MedClean Technologies Inc (PINK: MCLN) $0.0043 Stock has gained 2.38% with a healthy volume of 9.2 million shares. Today it broke the resistance of 50-day moving average, so keep a close eye on this puppy as more institutional traders look at the 50-day crossover to increase their positions. Company recently announced that it has signed a $700K contract with Sunbelt Medical Services, Inc.
Medclean Technologies, Inc. designs, sells, installs, and services on site turnkey systems to treat regulated medical waste. It provides MedClean series systems as solutions to incineration and off site hauling of untreated waste, and other alternative treatment technologies and methodologies.
Ambac Financial Group Inc. (PINK: ABKFQ) $0.178 Ambac surprised investors with another 14% gain, leaving them on a rollercoaster ride from the past few days as the price has been extremely volatile with hefty volume of 6.7 million shares. In our opinion, it has been gaining a lot of attention after Merril Lynch was ordered to pay $10 million for misusing customers’ information.
Ambac Financial Group, Inc., headquartered in New York City, is a holding company whose affiliates provide financial guarantees and financial services to clients in both the public and private sectors around the world. Ambac's principal operating subsidiary, Ambac Assurance Corporation, a guarantor of public finance and structured finance obligations, has double-A ratings from Standard & Poor's Ratings Services and Fitch, Inc. Moody's Investors Service, Inc. recently placed the triple-A ratings of Ambac Assurance on review for possible downgrade.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any stocks listed in this stock news report
